AIMD logo

Ainos, Inc. Common Stock


AIMD: Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form.


Show AIMD Financials

Consumer Interest
SEC Filings

Recent trades of AIMD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by AIMD's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Sensor with chamber Apr. 04, 2023
  • Patent Title: Smart drug injection device Nov. 15, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of AIMD in WallStreetBets Daily Discussion


Recent insights relating to AIMD

CNBC Recommendations

Recent picks made for AIMD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AIMD

Corporate Flights

Flights by private jets registered to AIMD